Sucampo Pharmaceuticals has appointed Alex Driggs as its new general counsel and corporate secretary.
Driggs joined the company in May 2015 as associate general counsel and was appointed deputy general counsel in September 2015. He has served since June 2017 as acting general counsel and corporate secretary, and reports to Sucampo chair and CEO Peter Greenleaf. He is based in the company’s headquarters in Rockville, Maryland.
Driggs succeeds Matthias Alder, who left the company to become chief business officer and general counsel of Autolus.
From January 2013 through May 2015, Driggs was an independent legal consultant for biotechnology clients. Before that he served as senior counsel in Amgen’s licensing and alliance management group. From 2009 until 2012, he was the associate general counsel for Micromet, a public biotechnology company.
‘Alex has extensive experience advising biotechnology and life sciences companies, and he has become an integral part of the Sucampo team in recent years,’ Greenleaf says in a statement. ‘He has a proven track record of offering expert legal counsel to our management and board of directors and we look forward to his increasingly important role as we advance our strategy to grow and advance our late-stage pipeline in highly specialized areas of significant unmet medical need.’
Ben Maiden
Ben Maiden is the editor-at-large of Governance Intelligence, an IR Media publication, having joined the company in December 2016. He is based in New York. Ben was previously managing editor of Compliance Reporter, covering regulatory and compliance...
